Formula & Concentration

Novoeight®, Antihemophilic Factor (Recombinant) For Intravenous Injection. Lyophilized Powder for Solution Initial

Manufacturer

Novo Nordisk

Indications

Novoeight is indicated for use in adults and children with hemophilia A for the control and prevention of bleeding, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.

Novoeight® is not indicated for the treatment of von Willebrand disease.

Product Options

Vial Size NDC
250 IU 0169-7825-01
500 IU 0169-7850-01
1000 IU 0169-7810-01
1500 IU 0169-7815-01
2000 IU 0169-7820-01
3000 IU 0169-7830-01

Shelf Life & Storage

Refrigerated up to thirty (30) months – Room temperature up to twelve (12) months / Store Novoeight under refrigeration at a temperature of 36°F-46°F (2°C – 8°C). Novoeight may also be stored at room temperature not to exceed 86°F (30°C).

Novoeight

To order, call

855-307-6880

or fax
602-850-6226
or email
canyoncarerx@canyoncarerx.com

Can't find what you are looking for?

Please call us and we would love to help.

855-307-6880